Patents by Inventor M. Neale Weitzmann

M. Neale Weitzmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-?B activation
    Patent number: 9301945
    Abstract: The disclosure is directed to methods for treating inflammatory conditions and cancers that have misregulated NF-?B. In some embodiments, the disclosure is directed to methods for treating inflammatory conditions, inflammatory states associated with treating HIV and AIDS infections, and cancers that include administering strontium ranelate to a subject diagnosed with or at risk of inflammatory conditions, inflammatory states, and cancers, respectively.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: April 5, 2016
    Assignee: Emory University
    Inventors: M. Neale Weitzmann, Masayoshi Yamaguchi
  • STIMULATING BONE FORMATION BY INHIBITION OF CD28 CO-STIMULATION
    Publication number: 20150232558
    Abstract: The disclosure relates to methods of growing bone or increasing bone mineral density and/or volume comprising administering an effective amount of a therapeutic containing abatacept or belatacept or other molecule that binds with CD8O, CD86, or CD28 providing inhibition of CD28 co-stimulation to a subject in need thereof.
    Type: Application
    Filed: October 30, 2013
    Publication date: August 20, 2015
    Inventor: M. Neale Weitzmann
  • METHODS FOR TREATING INFLAMATORY CONDITIONS AND STATES, AND CANCERS BY ANTAGONIZING NF-kB ACTIVATION
    Publication number: 20140163093
    Abstract: The disclosure is directed to methods for treating inflammatory conditions and cancers that have misregulated NF-?B. In some embodiments, the disclosure is directed to methods for treating inflammatory conditions, inflammatory states associated with treating HIV and AIDS infections, and cancers that include administering strontium ranelate to a subject diagnosed with or at risk of inflammatory conditions, inflammatory states, and cancers, respectively.
    Type: Application
    Filed: July 19, 2012
    Publication date: June 12, 2014
    Applicant: EMORY UNIVERSITY
    Inventors: M. Neale Weitzmann, Masayoshi Yamaguchi